Download A4Medicine Mobile App
Empower Your RCGP AKT Journey: Master the MCQs with Us! 🚀
In June 2022, the National Institute for Health and Care Excellence (NICE) released updated guidelines for the management of type 2 diabetes. These guidelines reflect the latest evidence and aim to improve the quality of care for individuals living with diabetes. Below is a summary of the main updates suggested by NICE:
| Category | Update |
|---|---|
| Diagnosis of Type 2 Diabetes | - HbA1c diagnostic threshold remains at 48 mmol/mol (6.5%), with a second test recommended for confirmation. - Fasting Plasma Glucose (FPG) threshold is 7.0 mmol/L (126 mg/dL). |
| Screening for High-Risk Groups | - Enhanced screening recommendations for individuals with a family history of diabetes, obesity, or certain ethnic backgrounds (e.g., South Asian, African-Caribbean). |
| Individualized Treatment Goals | - Treatment goals tailored to age, comorbidities, and patient preferences. - Personalized HbA1c targets based on health status and risk of complications. |
| Lifestyle Interventions | - First-line management includes lifestyle changes such as dietary adjustments and physical activity. - Structured education programs for self-management, dietary advice, and physical activity are recommended. |
| Pharmacological Management | - Metformin remains the first-line treatment. - SGLT2 inhibitors and GLP-1 receptor agonists recommended earlier for patients with cardiovascular risk. - Updated guidance on insulin initiation with emphasis on education and support. |
| Cardiovascular Risk... |
Try our Free Plan to get the full article.
